Lv31
308 积分 2023-07-16 加入
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
19天前
已完结
Regulation of GLP-1 and Glucagon Receptor Function by β-Arrestins in Metabolically Important Cell Types
25天前
已完结
The ubiquitination status of the glucagon receptor determines signal bias
25天前
已完结
236-OR: Volagidemab, a Human Glucagon Receptor Antagonist, Improves Glycemic Control in Subjects with Type 1 Diabetes (T1D): A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial
8个月前
已关闭
682-P: Novel Dual Glucagon and Glucagon-Like Peptide-1 Receptor Agonist LY3305677 Improves Glucose Control, Reduces Body Weight, and Increases Energy Expenditure in Mice
10个月前
已关闭
The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial Diseases
10个月前
已完结
G protein-coupled receptor signaling: transducers and effectors
10个月前
已完结
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial
11个月前
已完结
Continuously recording fluorescent assays optimized for five human matrix metalloproteinases
1年前
已完结
25 years of anti-TNF treatment for inflammatory bowel disease: lessons from the past and a look to the future
1年前
已完结
皖公网安备34019202002308
